The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre
Abstract
OBJECTIVES: In 2006, 0.6% of healthy subjects living in the Paris area had extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in their gut. To assess the evolution of this rate, a study identical to that of 2006 was conducted in 2011. PARTICIPANTS AND METHODS: Healthy adults who visited the IPC check-up centre in February-March 2011 and agreed to participate, provided stools and answered a questionnaire on the visit day. Stools were analysed to detect ESBL producers and to isolate the dominant E. coli population. ESBLs were molecularly characterized. For the subjects harbouring ESBL-producing E. coli, the phylogenetic group and sequence type (ST) were determined for both ESBL-producing and dominant E. coli isolates. PFGE profiles were also determined when two types of isolates had the same ST. RESULTS: Among the 345 subjects included, 21 (6%) had ESBL-producing E. coli faecal carriage. None of the previously published risk factors was identified. CTX-M accounted for 86% and SHV-12 for 14%. Dominant and ESBL-producing E. coli were similarly distributed into phylogenetic groups (A, 52%-48%; B1, 5%; B2, 24%-14%; and D, 19%-33%). Dominant and ESBL-producing E. coli displayed a polyclonal structure (18 STs each). However, ST10 and ST131 were identified in dominant and ESBL-producing E. coli isolates from different subjects. Most (20/21) ESBL producers were subdominant and belonged (16/21) to STs different from that of the corresponding dominant E. coli. CONCLUSIONS: The 10-fold increase in the rate of healthy subjects with ESBL-producing E. coli faecal carriage over a 5 year period suggests wide dissemination of these isolates in the Parisian community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Cited by
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
Karanika, S., Karantanos, T., Arvanitis, M., Grigoras, C., & Mylonakis, E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw283 · Cited by 453
Hocquet, D., Muller, A., & Bertrand, X. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.01.010 · Cited by 329
Self-citationA New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131
Banerjee, R., & Johnson, J. R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02824-14 · Cited by 268
Rottier, W. C., Bamberg, Y. R. P., Dorigo-Zetsma, J. W., van der Linden, P. D., Ammerlaan, H. S. M., & Bonten, M. J. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ121 · Cited by 61
Metadata
- Authors
- Nicolas-Chanoine, M.-H., Gruson, C., Bialek-Davenet, S., Bertrand, X., Thomas-Jean, F., Bert, F., Moyat, M., Meiller, E., Marcon, E., Danchin, N., Noussair, L., Moreau, R., & Leflon-Guibout, V.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11-09
- Volume
- 68
- Issue
- 3
- Pages
- 562-568
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2161155576
- Cited by
- 168
- References
- 1
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. https://app.cochat.ai/papers/10.1093/jac/dks429
- The paper
- Nicolas-Chanoine, M.-H., Gruson, C., Bialek-Davenet, S., Bertrand, X., Thomas-Jean, F., Bert, F., Moyat, M., Meiller, E., Marcon, E., Danchin, N., Noussair, L., Moreau, R., & Leflon-Guibout, V. (2013). 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dks429
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.